Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2016

These securities consist of the following (in thousands):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2016		2015		2016		2015
Outstanding stock options		22,232		20,138		22,232		20,138
Warrant to purchase common stock		200		200		200		200
Purchase Plan		247		223		156		144
		22,679		20,561		22,588		20,482